URS
HZNP

Utah Retirement Systems’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Utah Retirement Systems’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,500
Closed -$4.45M – 1000
2023
Q3 		$4.45M Buy
38,500
+200
+0.5% +$21.5K 0.06% 300
2023
Q2 		$3.94M Sell
38,300
-1,100
-3% -$116K 0.05% 348
2023
Q1 		$4.3M Buy
39,400
+100
+0.3% +$11.1K 0.06% 327
2022
Q4 		$4.47M Sell
39,300
-900
-2% -$74.8K 0.07% 292
2022
Q3 		$2.49M Buy
40,200
+200
+0.5% +$14K 0.04% 407
2022
Q2 		$3.19M Buy
40,000
+1,100
+3% +$104K 0.05% 354
2022
Q1 		$4.09M Sell
38,900
-700
-2% -$68.2K 0.05% 341
2021
Q4 		$4.27M Buy
39,600
+100
+0.3% +$10.9K 0.05% 351
2021
Q3 		$4.33M Sell
39,500
-2,100
-5% -$218K 0.06% 329
2021
Q2 		$3.9M Buy
41,600
+4,100
+11% +$377K 0.05% 376
2021
Q1 		$3.45M Sell
37,500
-1,700
-4% -$143K 0.05% 379
2020
Q4 		$2.87M Buy
39,200
+1,700
+5% +$126K 0.04% 430
2020
Q3 		$2.91M Buy
37,500
+29,800
+387% +$2.05M 0.05% 361
2020
Q2 		$428K Sell
7,700
-100
-1% -$4.28K 0.01% 850
2020
Q1 		$231K Hold
7,800
– – 0.01% 885
2019
Q4 		$282K Buy
7,800
+100
+1% +$3.07K 0.01% 919
2019
Q3 		$210K Buy
+7,700
New +$199K ﹤0.01% 942

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Utah Retirement Systems's HZNP Position: Q4 2023 in Review

Utah Retirement Systems sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 38,500 shares — an estimated $4.45M sold.

Utah Retirement Systems first reported a position in HZNP in Q3 2019 and held it in 17 quarters. The position peaked at $4.47M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Utah Retirement Systems reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Utah Retirement Systems sold 38,500 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.45M.
  • Utah Retirement Systems first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 17 quarters.
  • Utah Retirement Systems's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.47M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Utah Retirement Systems's 13F filing for Q4 2023, filed 14 Feb 2024.